Spanish Drug Group Acquired by AMRI

Thursday, July 16, 2015

Source: Albany Business Review

Albany Molecular Research Inc. announced today that it has acquired a private drug development company in Spain for $174 million.
The Albany, New York drug development company acquired Gadea Pharmaceutical Group, which develops active pharmaceutical ingredients.

View All News »